Archive for the 'Cancer' Category

European ancestry increases breast cancer risk

Latina women have a lower risk of breast cancer than European or African-American women generally, but those with higher European ancestry could be at increased risk, as per details reported in the December 1 issue of Cancer Research, a journal of the American organization for Cancer Research. “We…

Prostate cancer spurs new nerves

Prostate cancer and perhaps other cancers promotes the growth of new nerves and the branching axons that carry their messages, a finding linked to more aggressive tumors, said scientists from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinic…

Potential new drug target for chronic leukemia

Scientists at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Center have discovered what could be a novel drug target for an often difficult-to-treat style of leukemia. The researchers have identified a different “signature” or sample of a specific family of enzymes in pa…

Suppressing prostate cancer development

Scientists at the University of Southern California (USC) have observed that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models. Scientists say the upcoming study in the Proceedings of the National Academy of Sciencesnow avail…

Role of vitamin D in cancer therapy

A colon cancer cell isn’t a lost cause. Vitamin D can tame the rogue cell by adjusting everything from its gene expression to its cytoskeleton. In the Nov. 17 issue of the Journal of Cell Biology, Ordez-Morn et al. show that one pathway governs the vitamin’s diverse effects. The results help clarif…

If the diabetes has a direct carcinogenetic effect?

The organization of DM2 with solid tumors, and particularly with HCC, has been faraway suspected and several studies have reported increased mortality rates for neoplastic diseases in patients with DM2. However, the temporal relationship amidst onset of diabetes and development of HCC, and the clin…

Scientists shut in on method to fight deadly childhood cancer

A multicenter team of researchers, including researchers from the University of Florida, has discovered a way to potentially block the growth of neuroblastoma, a type of cancer responsible for 15 percent of all cancer deaths in children. Working with human cell lines and tissue samples, scientists …

Multiple Myeloma Research Consortium Initiates Phase 1B Study Of Elotuzumab Monoclonal Antibody In Combination With REVLIMID And Dexamethasone

The Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a three-drug combination study of elotuzumab (also known as HuLuc63), a humanized anti-CS1 monoclonal IgG1 antibody administered intravenously, in combination with REVLIMID® (lenalidomide), and dexamethasone for the…

Looking Forward To A Better Treatment For Childhood Cancer

Children who are diagnosed with cancer could benefit from better diagnosis and treatment in the future thanks to a new research project involving clinicians and scientists at The University of Nottingham. Experts at the University are part of the Children’s Cancer and Leukaemia Group which has ju…

Georgetown University Medical Center Researcher Elected To Institute Of Medicine

The Institute of Medicine, part of the National Academy of Sciences, has announced the membership election of Lucile L. Adams-Campbell, PhD, associate director for minority health and health disparities research, and professor of oncology at Georgetown University Medical Center’s Lombardi Comprehens…

Yale Scientists Identify Genetic Marker To Predict Lung Cancer Risk

Yale Cancer Center researchers have identified a genetic biomarker that may help to determine why some society are at an increased risk of developing lung cancer. The findings, published in the journal Cancer Research, could help identify smokers who should be carefully screened for lung cance…

Next Page »